radiopharmaceuticals

You have access
Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy
Julie Bolcaen, Mohamed A. Gizawy, Samantha Y.A. Terry, António Paulo, Bart Cornelissen, Aruna Korde, Jonathan Engle, Valery Radchenko and Roger W. Howell

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1344-1351; DOI: https://doi.org/10.2967/jnumed.122.265039
You have access
Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais

Journal of Nuclear Medicine August 17, 2023, jnumed.123.265916; DOI: https://doi.org/10.2967/jnumed.123.265916
You have access
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals
Lukas M. Carter, Juan C. Ocampo Ramos, Edmond A. Olguin, Justin L. Brown, Daniel Lafontaine, Derek W. Jokisch, Wesley E. Bolch and Adam L. Kesner

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1295-1303; DOI: https://doi.org/10.2967/jnumed.122.264230
You have access
¹⁸F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use
Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren and Christophe M. Deroose

Journal of Nuclear Medicine June 1, 2023, 64 (6) 835-841; DOI: https://doi.org/10.2967/jnumed.123.265622
Open Access
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M. Gudenkauf, Melody N. Chavez, Melinda Leigh Maconi, Carley Geiss, Ameen Seyedroudbari, Pan Thin, Aasha I. Hoogland, Kathleen Nguyen, Vishnu Murthy, Wesley R. Armstrong, Khaled Komrokji, Laura B. Oswald, Heather S.L. Jim, Ghassan El-Haddad, Wolfgang P. Fendler, Ken Herrmann, David Cella, Johannes Czernin, Michael S. Hofman, Adam P. Dicker, Jeremie Calais, Scott T. Tagawa and Brian D. Gonzalez

Journal of Nuclear Medicine June 1, 2023, 64 (6) 869-872; DOI: https://doi.org/10.2967/jnumed.122.264946
Open Access
First-in-Humans Evaluation of Safety and Dosimetry of ⁶⁴Cu-LLP2A for PET Imaging
Richard Laforest, Anchal Ghai, Tyler J. Fraum, Reiko Oyama, Jennifer Frye, Helen Kaemmerer, Greg Gaehle, Tom Voller, Cedric Mpoy, Buck E. Rogers, Mark Fiala, Kooresh I. Shoghi, Samuel Achilefu, Michael Rettig, Ravi Vij, John F. DiPersio, Sally Schwarz, Monica Shokeen and Farrokh Dehdashti

Journal of Nuclear Medicine February 1, 2023, 64 (2) 320-328; DOI: https://doi.org/10.2967/jnumed.122.264349
You have access
Single-Domain Antibody Theranostics on the Horizon
Weijun Wei, Muhsin H. Younis, Xiaoli Lan, Jianjun Liu and Weibo Cai

Journal of Nuclear Medicine October 1, 2022, 63 (10) 1475-1479; DOI: https://doi.org/10.2967/jnumed.122.263907
You have access
Pretargeting: A Path Forward for Radioimmunotherapy
Sarah M. Cheal, Sebastian K. Chung, Brett A. Vaughn, Nai-Kong V. Cheung and Steven M. Larson

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1302-1315; DOI: https://doi.org/10.2967/jnumed.121.262186
You have access
Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W. Schwarz, Peter J.H. Scott, Henry F. VanBrocklin, Steven S. Zigler and on behalf of the Coalition of Drug Manufacturers

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.121.263443
You have access
RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
Michael G. Stabin, Richard E. Wendt and Glenn D. Flux

Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034

Main menu

User menu

Search

radiopharmaceuticals

Pages